One of the trends in the healthcare industry
is the advent of direct access testing (DAT). DAT represents
a de-formalization of traditional healthcare, allowing consumers
the opportunity to access the laboratory without having to consult
a physician. While it appears unlikely that DAT will supplant
traditional healthcare, it does appear that the characteristics
which make DAT appealing will propel it to a significant role
in the healthcare arena.
Without a Physician
DAT is a service that allows consumers to obtain laboratory-type
testing without consulting a physician. It is defined as
consumer-initiated testing of human specimens. However, it
is up to the consumer to decide what tests should be performed.
Laboratory personnel are not licensed to practice medicine;
however, "laboratory results not explained to a patient (in
writing or in conversation) establish a duty of patient care
relationship that is enforced in a court of law."
Even when laboratories employ physicians to meet certain insurance
requirements, the extent to which they can advise the patient
is limited by both regulatory statutes and potential civil litigation.
However, test results often come with
generic information about the test and what the results may
mean. Consequently, customers are generally on their own to
find a physician to study and evaluate the information to determine
an appropriate response.
Formats for DAT
Laboratories involved in DAT retain the same obligations that
they have with traditional, physician-ordered tests. In general:
- tests should be performed properly,
- results should be reliable,
- results should be communicated properly to the individual
ordering the test, and
- medical information is privileged.
There are essentially four formats for DAT. The first of these
is the walk-in laboratory, where trained staff (typically a phlebotomist)
is available to assist in sample collection. This method allows
for better specimens and, because more complicated samples may
be collected, the laboratory can conduct a broader range of tests.
Results are reported in a variety of ways, depending upon the
test and the policy of the testing lab.
The second of the formats for DAT is the mail-order lab test.
These tests usually involve a collection kit, where the patient
collects his own sample. Typically, the tests which are susceptible
to improper collection (e.g., blood hemolysis) may not be appropriate
within this method. Results are often reported via phone or mail.
The third laboratory format available to patients seeking self-diagnosis
is in fact a de facto form of DAT. This arena involves
blood donor processing facilities, where donated blood is screened
for a variety of diseases, such as hepatitis and HIV. While donors
are discouraged from donating blood to obtain free screening,
it is likely that this in fact does occur. In this case, patients
are typically notified by mail.
The fourth and final format for DAT is the at-home test kit.
In this case, it is up to the patient to collect the sample,
perform the test, interpret the results, and determine the appropriate
medical response. Obviously, this type of testing includes only
those evaluations that are simple to perform and interpret.
Emergence
To a certain extent, DAT has evolved in concert with the development
of point-of-care testing and technology. Cost-reduction efforts
in the medical field included reduced hospitalization and general
de-formalizationpatients were treated on an outpatient basis,
often by an assistant or nurse (or even pharmacist). To this
effect, the walk-in lab became an extension of outpatient treatment.
Meanwhile, technological advances allowed for more reliable
test methods that were, in many instances, easier to perform.
Consequently, more and more tests were adapted for use at home,
as patients assumed new responsibilities for their healthcare.
The FDA has approved numerous kits that allow the patient to
either perform the test at home, or to collect the sample at
home and mail it to the laboratory for testing. The most common
home tests include: pregnancy indicators, ovulation predictors
and blood glucose monitors, while home sample collection kits
include tests that require a small sample of dried blood (e.g.,
HIV) or other specimen.
Acceptance
Given the dynamics of the World Wide Web, data is, in essence,
available anywhere there is access to the Internet. Presently,
no federal statutes restrict test ordering or release of results
to patients. However, many states have introduced legislation
to regulate DAT. States that presently have restrictions on
DAT include California, Nevada, Utah, Missouri, Arkansas, Illinois,
Mississippi, Michigan, New York, Maine, New Jersey, Maryland,
Arizona, Oregon, Idaho, Wyoming, North Dakota, Iowa, Kentucky,
Tennessee, Alabama, Georgia, Florida, South Carolina, North
Carolina, Pennsylvania, Massachusetts, Rhode Island, Connecticut
and Hawaii. Puerto Rico also has restrictions.
Advantages
Inherent in this form of healthcare are several advantages. Advocates
of DAT point toward cost savings to the consumer, convenience,
improved privacy and, most importantly, greater controls of
one's own healthcare. The most highly touted advantage of DAT
appears to be reduced cost to the consumer. Lab-sponsored Web
sites indicate that customers can reduce their medial bills
by 40 to 70 percent. Indeed, many employers have relied upon
DAT as a low-cost option to screen workers for drug use (with
a more formalized test for those who demonstrate positive results).
Moreover, physicians will often refer patients who lack the
ability to pay for healthcare to this type of testing due to
its increased affordability. However, because most insurance
plans do not pay for tests unless prescribed by a physician,
the potential cost savings are not available to a large segment
of the population. Thus, it appears that cost avoidance may
in fact be less significant than the convenience and privacy
of DAT.
For many customers, the issue of DAT has more to do with convenience
than anything else. Within the framework of traditional healthcare,
the patient would have to make an appointment (often necessitating
an absence from work), spend time traveling to the physician's
office, wait for the physician to become available, have the
test performed and, in many cases, repeat the entire process
several days later to receive the results.
With DAT, consumers can obtain laboratory evaluation with little
or no interruption of their daily activities. No doubt, the primary
advantages of the home pregnancy test kit and glucose monitoring
devices are convenience. Other DATs that appeal because of convenience
include mammograms, PSA screening, glucose monitoring and cholesterol
testing.
For patients who are embarrassed or concerned with the stigma
associated with certain tests (such as screenings for sexually
transmitted diseases or drug use), the main advantage of DAT
is privacy. Increased discretion is also of concern to many patients
who fear that documentation in their medial files may result
in denied health or life insurance, or even employment. In particular,
a higher level of privacy is often appealing to patients in rural
areas, who frequently have nonprofessional relationships with
the only healthcare workers available. To this effect, the anonymous
nature of DAT provides a vehicle whereby these individuals can
determine their health status.
The advantages of DAT involve potentially reduced costs, greater
convenience and increased privacy. The primary advantage of DAT,
however, may be due to increased accessibility to healthcare
services. Consumers who might avoid testing due to financial
limitations, time constraints or embarrassment may find DAT more
suitable for their circumstances. Thus, individuals who otherwise
would be unaware or uninformed of medical issues may be inspired
to seek additional medical help or treatment to resolve problems
that were revealed vis a vis direct access to laboratory
testing.
In addition to providing benefits for consumers,
DAT also offers advantages for the laboratory. The primary advantages
here include putting the labs in new, direct relationships with
patients; increased business, and up-front payment for services
rendered.
Consumers
DAT appeals to consumers who have had healthcare episodes
that have heightened their concern for their health,
including those with chronic diseases. To this effect,
DAT offers the advantages of price, convenience and
privacy. While lower cost often is touted as a way
to make healthcare more affordable for the financially
disadvantaged, there is evidence to suggest that the
largest segment of DAT consumers are middle class patrons
who prefer the convenience and/or privacy that this
type of testing offers. In fact, since most insurance
plans do not cover DAT, these customers actually end
up paying more for direct access tests than they would
have paid via the traditional format.
Another feature of the DAT market is that nearly all
of the business is conducted via the Internet. Even
though some laboratories have begun establishing storefront
facilities to improve accessibility to consumers, the
overwhelming majority of tests are ordered online.
Thus, it appears that the typical DAT customer is a
middle-class individual who values convenience and
privacy, and who prefers to order and schedule tests
over the Internet.
Disadvantages
Problems with DAT include potential misinterpretation
of test results by the patient, potential lack of confidentiality,
lack of proper follow-up in cases where treatment or
other action is important or even required by law (such
as government notification), and finally, the increased
opportunity for fraudulent or incompetent testing.
To this effect, many states have enacted regulations
that attempt to restrict or even prohibit DAT.
Laboratory directors must be aware that giving patients
access to their test results is not as easy as it sounds.
Down the road of DAT, there are some disadvantages, concerns,
and possible pitfalls for both the laboratory and the
patient. One of the biggest problems with DAT is the
possibility of the patient misinterpreting test results.
Patients may not know the significance of a test and
believe that out-of-range results should be interpreted
as a disease state and normal results are interpreted
as no disease state. A concern of the lab is the extent
of result interpretation by laboratory professionals.
It is possible that DAT would put the laboratory in a
position it has never experienced thus far. Result interpretation
and recommendations of treatment by the lab would put
them in a role of patient care and bring about new ethical
issues and increased liability for the lab. To avoid
such a situation, laboratories should include a disclaimer
with all DAT reports indicating that the interpretation
of test results is a medial matter, which is best undertaken
by the patient and his physician. Also, the disclaimer
should state firmly that the laboratory only provides
information and does not and will not interpret the results.
Responsibility
Another issue of DAT is the privacy and security of results.
Many of the test results are received by the patients
via the Internet and thus can pose a security problem.
The Health and Privacy Project, which is being conducted
at Georgetown University, has released a report that
questions the privacy and security of some of the 21
healthcare Internet portals researched. They found
that visitors to many of the sites were not anonymous
because mechanisms such as cookies and click streams
allowed third parties to collect information about
people without their knowledge or consent. Also, they
found that many of the sites don't even follow their
own privacy policies. Laboratories that partner with
an Internet portal should make sure that all of the
services provided through the Internet portal meet
the requirements of HIPAA security regulations.
Another concern with DAT is the potential for customers
to fail to react properly when presented with important
lab information. While failure to consult medical help
upon receipt of significant lab findings is one concern,
an ever-greater issue revolves around contagious and
reportable diseases such as HIV. Such diseases can impact
more than the individual being tested, and positive results
often incur responsibility for notification of potentially
exposed individuals as well as governmental institutions.
An additional concern with DAT is the potential for
fraud and incompetent testing. While the typical brick
and mortar facilities of traditional physicians' offices
and healthcare agencies are fairly easy to regulate,
Internet suppliers are often difficult to track and control.
Consumers ordering home test kits may receive results
from a lab that uses poor testing procedures.
In some instances, the tests
may be complete frauds that provide results that have
no validity whatsoever—as
in the case of Lei-Home Access HIV, which involved the
distribution of fake HIV test kits.
Here to Stay
Some predict that DAT may account for as much as 10 percent
of all lab testing within the next few years. While
substantial cost savings to consumers have yet to be
realized (primarily due to the fact that many insurance
companies do not cover DAT), it appears likely that
this may change in the near future.
A final concern involving DAT revolves around profitability
for the lab. Expenses for advertising, as well as labor
costs for medical technologists, put a damper on the
supply side of DAT. In essence, DAT does not represent
an overnight success, but with determination, it can
increase revenue and eliminate the middleman while giving
customers a greater role and improved convenience in
their healthcare.
For DAT to be profitable, labs will have to develop
repeat customers. Another facet, made possible due to
advances in technology, is an increased variety of tests
available to consumers.
Thus, given the development of a repeat customer base
and the potential for an increased variety of testing
options, it appears that DAT may indeed represent a lucrative
arena for clinical laboratories.
Regina Goodrum, Elaine Miller and Randall Reeves are
graduates of the medical technology program at Armstrong
Atlantic State University, Savannah, GA. Dr. Aziz
is the Department Head of Medical Technology at Armstrong
Atlantic State University.
|
|